Navigation Links
Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline
Date:12/27/2019

Vici Health Sciences is announcing its successful completion of initial clinical studies for its 505(b)(2) product pipeline that offers patients and healthcare providers options in the treatment of chronic diseases that disproportionately affect geriatric patients. The products concepts were identified in collaboration with doctors and managed care professionals and developed at Vici’s R&D facility in Maryland. Vici has completed first round of communication with FDA and is currently working on scaling up the manufacturing process in anticipation of entering the registration phase of the project. Simultaneously Vici is in talks with its commercialization partners to ensure that doctors and patients have full access to these products that will significantly help improve patient outcomes.

About Vici Health Sciences LLC
Vici Health Sciences (Vici) is a U.S. based pharmaceutical research and development company. Vici is focused on specialty branded and generic pharmaceutical product development and commercialization. Vici’s goal is to improve clinical outcomes, enhance access, and reduce costs for patients and healthcare providers.

Read the full story at https://www.prweb.com/releases/vici_health_sciences_is_announcing_its_successful_completion_of_initial_clinical_studies_for_its_505b2_product_pipeline/prweb16807389.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology technology :

1. Focal Healthcare’s Fusion Bx 2.0 Targeted Prostate Biopsy Solution Receives CE Mark
2. Leading Experiential Marketing Agency, Sparks, Invests in Healthcare Marketing Firm, Bichsel Medical Marketing Group
3. Tech PR Firm ARPR Honored as a Health Care PR Agency of the Year; Grows HealthIT Practice Group 18% Quarter-Over-Quarter
4. BHIP Takes Aim at Teenagers’ Stress, Anxiety, Executive Function, Interpersonal Skills, and Overall Mental Health
5. eKare’s inSight Joins the NHS Digital Health Accelerator Program
6. Advancements Announces New Episode Focusing on Innovations in Health, Medicine, and Technology
7. MyBioGate Global Healthcare Innovation Competition Boston Preliminary Successfully Came to the Conclusion
8. Visikol Presents on Imaging 3D Cell Culture Models at the National Institute of Health
9. VetStem Biopharma, Parent Company of Personalized Stem Cells, is Approved for Stem Cell Manufacturing by the California Department of Public Health
10. Centura Health’s Innovative Patient Experience Initiative for Needle-Free Blood Draws
11. uBiome Awards Grant to North Carolina A&T State University to Study Gut Microbiome and Cardiovascular Health Risks in African-American Athletes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2020)... (PRWEB) , ... July 30, ... ... of cloud-based software for the life sciences industry, today announced the release ... platform designed specifically for Medical Science Liaisons (MSLs) and other field medical ...
(Date:7/18/2020)... ... July 17, 2020 , ... ... for the life sciences and food industries, is pleased to announce that Charles ... Research – Business Development. , Charles is an accomplished and results-driven sales executive ...
(Date:7/7/2020)... SAN DIEGO (PRWEB) , ... July 06, 2020 , ... ... a new program featuring up to 200 million stem cells. Depending on the patient's ... of seniors in the US will die having some form of Alzheimers dementia, and ...
(Date:6/28/2020)... ... , ... The Indoor Lab, a leading provider of sensor solutions for monitoring ... to ensure cleanliness, distancing and occupancy with its patent pending WipeAway™ technology using Artificial ... provide a health performance index system that scores all aspects of compliance similar to ...
Breaking Biology Technology:
(Date:7/18/2020)... ... 2020 , ... A study has been published in the ... noise control device to attenuate typical noises in a simulated neonatal intensive care ... sounds from patient monitors, ventilators and other bedside devices that would affect the ...
(Date:7/4/2020)... ... July 03, 2020 , ... Aesthetics Biomedical (ABM), ... multiple awards for not only the products and treatments developed, but also the ... Microneedle RF. All the brands built by ABM have received several honors already ...
(Date:7/1/2020)... ... July 01, 2020 , ... Cure Glioblastoma, ... glioblastoma—the most common and aggressive adult brain cancer—announced today the appointments of its ... are charged with supporting the organization’s initiatives and overall vision. , "Senior Fellows ...
Breaking Biology News(10 mins):